Camp4 Therapeutics Patents – Insights & Stats (Updated 2023)

Camp4 Therapeutics has a total of 39 patents globally, out of which 2 have been granted. Of these 39 patents, more than 51% patents are active. United States of America is where Camp4 Therapeutics has filed the maximum number of patents, followed by Europe and Hong Kong (S.A.R.). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Camp4 Therapeutics.

Camp4 Therapeutics was founded in the year 2016. The Company operates as a bio-technology company. The Company develops therapies for the treatment of various deceases.

Do read about some of the most popular patents of Camp4 Therapeutics which have been covered by us in this article and also you can find Camp4 Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Camp4 Therapeutics patent portfolio.

How many patents does the founder and the CEO of Camp4 Therapeutics have?

The founders Leonard Zon has 0 patent and Richard Young has 0 patent and CEO Josh Mandel-Brehm has 0 patent.

How many patents does Camp4 Therapeutics have?

Camp4 Therapeutics has a total of 39 patents globally. These patents belong to 11 unique patent families. Out of 39 patents, 20 patents are active.

How Many Patents did Camp4 Therapeutics File Every Year?

Camp4 Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCamp4 Therapeutics Applications FiledCamp4 Therapeutics Patents Granted
202311
202241
20211
20206
201914
201813

How many Camp4 Therapeutics patents are Alive/Dead?

Camp4 Therapeutics Patent Portfolio

How Many Patents did Camp4 Therapeutics File in Different Countries?

Camp4 Therapeutics Worldwide Patent Filing

Countries in which Camp4 Therapeutics Filed Patents

CountryPatents
United States Of America11
Europe5
Hong Kong (S.A.R.)4
Canada4
China3

Where are Research Centres of Camp4 Therapeutics Patents Located?

The Research Centre for all the Camp4 Therapeutics patents is the United States of America.

10 Best Camp4 Therapeutics Patents

US20210254056A1 is the most popular patent in the Camp4 Therapeutics portfolio. It has received 47 citations so far from companies like Mary Kay Inc., Listen Technologies Corporation and Abbvie Inc.

Below is the list of 10 most cited patents of Camp4 Therapeutics:

Publication NumberCitation Count
US20210254056A147
WO2019036430A19
WO2020037069A15
WO2020081329A14
US20200208128A13
WO2019195854A13
US20210118524A12
CN111094581A2
WO2019195855A12
WO2019195789A12

What Percentage of Camp4 Therapeutics US Patent Applications were Granted?

Camp4 Therapeutics (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 50.0%.

Below are the key stats of Camp4 Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Camp4 Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Goodwin Procter Llp950.00%

List of Camp4 Therapeutics Patents

Camp4 Therapeutics PatentsTitle
US11542290B2Phenothiazine Derivatives And Uses Thereof
US11266655B2Methods And Compositions For Treating Urea Cycle Disorders
US20230282314A1Characterizing Functional Regulatory Elements Using Machine Learning
US20230257410A1Phenothiazine Derivatives And Uses Thereof
US20220168316A1Methods And Compositions For Treating Urea Cycle Disorders
US20220107328A1Methods Of Treating Liver Diseases
US20210118524A1Identifying Therapeutic Targets By Discovering Interactions Between Non-Coding Variants And Candidate Genes
US20200208128A1Methods Of Treating Liver Diseases
EP3773597A4Phenothiazine Derivatives And Uses Thereof
EP3668993A4Methods Of Treating Liver Diseases
CN111447934AMethods And Compositions For Treating Urea Cycle Disorders, In Particular Otc Deficiency
CN111094581AMethods Of Treating Liver Diseases
WO2023034983A3Modulation Of Gene Transcription Using Antisense Oligonucleotides Targeting Regulatory Rnas
WO2023122762A1Modulation Of Gene Transcription Using Antisense Oligonucleotides Targeting Regulatory Rnas
CA3094481A1Phenothiazine Derivatives And Uses Thereof
CA3072346A1Methods Of Treating Liver Diseases
HK40046680APhenothiazine Derivatives And Uses Thereof
HK40032170AMethods And Compositions For Treating Urea Cycle Disorders, In Particular Otc Deficiency
HK40030309AMethods Of Treating Liver Diseases
HK40029501AMethods Of Treating Liver Diseases
US20210254056A1Identification And Targeted Modulation Of Gene Signaling Networks
US20210161997A1Treating Diseases Via Targeted Modulation Of Gene Signaling Networks
US20200316038A1Methods And Compositions For Treating Urea Cycle Disorders, In Particular Otc Deficiency
EP3836929A1Methods Of Treating Liver Diseases
EP3773618A1Treating Diseases Via Targeted Modulation Of Gene Signaling Networks
EP3691656A1Methods And Compositions For Treating Urea Cycle Disorders, In Particular Otc Deficiency
CN111971063ATreating Diseases Via Targeted Modulation Of Gene Signaling Networks
WO2020210642A1Methods And Compositions For Treating Urea Cycle Disorders
WO2020081329A1Methods And Compositions For Modulating Pcsk9 And Angptl3 Expression
WO2020037069A1Methods Of Treating Liver Diseases
WO2019195854A1Compositions And Methods For Treating Phenylketonuria
WO2019195855A1Treating Diseases Via Targeted Modulation Of Gene Signaling Networks
WO2019195789A1Phenothiazine Derivatives And Uses Thereof
WO2019071276A1Methods And Compositions For Treating Urea Cycle Disorders, In Particular Otc Deficiency
WO2019036430A1Methods Of Treating Liver Diseases
WO2018204764A1Identification And Targeted Modulation Of Gene Signaling Networks
WO2018204762A1Methods And Compositions Of Modeling Diseases With Hematopoietic Cell Systems
CA3095040A1Treating Diseases Via Targeted Modulation Of Gene Signaling Networks
CA3078247A1Methods And Compositions For Treating Urea Cycle Disorders, In Particular Otc Deficiency

What are Camp4 Therapeutics key innovation segments?

What Technologies are Covered by Camp4 Therapeutics?

The chart below distributes patents filed by Camp4 Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Camp4 Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Camp4 Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Camp4 Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.